Thrombomodulin in intensive care patients
- PMID: 8522668
- DOI: 10.1007/BF01711542
Thrombomodulin in intensive care patients
Retraction in
-
Retraction Note: Thrombomodulin in intensive care patients.Intensive Care Med. 2023 Aug;49(8):1048. doi: 10.1007/s00134-023-07142-4. Intensive Care Med. 2023. PMID: 37341744 No abstract available.
Abstract
Objective: Changes of endothelial-related coagulation was studied in intensive care patients.
Design: Descriptive, prospective.
Setting: Clinical investigation, intensive care unit of an university hospital.
Patients: 40 consecutive critically ill patients with severe trauma (n = 20) or postoperative complications (n = 20) were studied. 14 patients suffered from sepsis, 12 patients suffered from acute renal failure.
Interventions: 12 patients with acute renal failure were continuously hemofiltrated. All patients were on continuous sedation (fentanyl and midazolam) and mechanical ventilation.
Measurements: In addition to standard coagulation variables, thrombomodulin (TM), protein C and protein S as well as thrombin/antithrombin III (TAT) plasma concentrations were measured from arterial blood samples using enzyme-linked immuno-sorbent assays (ELISA). Measurements were carried out on the day of admission (trauma patients) or on the day of diagnosis of sepsis and during the next 4 days.
Main results: Throughout the entire investigation period, TM plasma concentrations in patients with sepsis (baseline: 90 +/- 25 micrograms/l, 4th day: 152 +/- 28 micrograms/l) were significantly higher than in non-septic patients (baseline: 60 +/- 29 micrograms/l, 4th day: 42 +/- 15 micrograms/l). 15 of the 40 patients died within or after the end of the investigation period. TM plasma concentrations of survivors were lower (maximum: 63 +/- 18 micrograms/l) than in the non-survivors (maximum: 159 +/- 22 micrograms/l) (p < 0.05). Hemofiltered patients showed higher TM plasma levels, which further increased during the hemofiltration procedure. Protein C and (free) protein S were without significant group differences. TAT plasma levels were elevated above normal in all patients (no group differences).
Conclusions: Besides plasmatic and platelet-related coagulation, endothelium-associated coagulation appears to be also important for maintenance of hemostasis. TM plasma concentrations were elevated in all our critically ill patients, particularly when sepsis was evident. This appears to be most likely due to endothelial membrane damage with increased release of membrane-bound TM into the circulating blood in these patients. The importance of the elevated plasma levels of circulating soluble TM on hemostasis in these patients is an ongoing debate and warrants further studies.
Similar articles
-
Influence of long-term continuous intravenous administration of pentoxifylline on endothelial-related coagulation in critically ill patients.Crit Care Med. 1996 Jun;24(6):940-6. doi: 10.1097/00003246-199606000-00011. Crit Care Med. 1996. Retraction in: Crit Care Med. 2023 Sep 1;51(9):e199. doi: 10.1097/CCM.0000000000005911. PMID: 8681595 Retracted. Clinical Trial.
-
Does the type of volume therapy influence endothelial-related coagulation in the critically ill?Br J Anaesth. 1995 Dec;75(6):740-6. doi: 10.1093/bja/75.6.740. Br J Anaesth. 1995. Retraction in: Br J Anaesth. 2020 Sep;125(3):415. doi: 10.1016/j.bja.2020.07.034. PMID: 8672323 Retracted. Clinical Trial.
-
Changes of the hemostatic network in critically ill patients--is there a difference between sepsis, trauma, and neurosurgery patients?Crit Care Med. 2000 Feb;28(2):445-50. doi: 10.1097/00003246-200002000-00026. Crit Care Med. 2000. PMID: 10708181
-
Revisiting the activated protein C-protein S-thrombomodulin ternary pathway: Impact of new understanding on its laboratory investigation.Transfus Apher Sci. 2019 Aug;58(4):538-544. doi: 10.1016/j.transci.2019.06.008. Epub 2019 Jun 22. Transfus Apher Sci. 2019. PMID: 31256946 Review.
-
Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients.Crit Care Med. 1996 Mar;24(3):385-91. doi: 10.1097/00003246-199603000-00005. Crit Care Med. 1996. Retraction in: Crit Care Med. 2023 Sep 1;51(9):e198. doi: 10.1097/CCM.0000000000005910. PMID: 8625624 Retracted. Review.
Cited by
-
Pro-Coagulant Endothelial Dysfunction Results from EHEC Shiga Toxins and Host Damage-Associated Molecular Patterns.Front Immunol. 2015 Apr 7;6:155. doi: 10.3389/fimmu.2015.00155. eCollection 2015. Front Immunol. 2015. PMID: 25904918 Free PMC article.
-
Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.Evid Based Complement Alternat Med. 2010 Dec;7(4):501-10. doi: 10.1093/ecam/nep152. Epub 2009 Sep 24. Evid Based Complement Alternat Med. 2010. PMID: 19779008 Free PMC article.
-
Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin.Crit Care. 2017 Aug 25;21(1):229. doi: 10.1186/s13054-017-1815-x. Crit Care. 2017. PMID: 28841902 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical